Cilostazol labels and packages: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) No edit summary |
|||
| Line 4: | Line 4: | ||
==Labels and Packages== | ==Labels and Packages== | ||
'''PRINCIPAL DISPLAY PANEL - 50mg Bottle Label''' | |||
NDC 59148-003-16 | |||
Tablets | |||
'''PLETAL®''' | |||
(cilostazol) | |||
'''50mg | |||
OTSUKA AMERICA | |||
PHARMACEUTICAL, INC. | |||
60 TABLETS''' | |||
{| | {| | ||
|[[File:Pletal50mg.JPG|600px|thumb]] | |[[File:Pletal50mg.JPG|600px|thumb]] | ||
|} | |} | ||
'''PRINCIPAL DISPLAY PANEL - 100mg Bottle Label''' | |||
NDC 59148-002-16 | |||
Tablets | |||
'''PLETAL®''' | |||
(cilostazol) | |||
100mg | |||
'''OTSUKA AMERICA | |||
PHARMACEUTICAL, INC.''' | |||
60 TABLETS | |||
{| | {| | ||
|[[File:Pletal100mg.JPG|600px|thumb]] | |[[File:Pletal100mg.JPG|600px|thumb]] | ||
|}<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = PLETAL (CILOSTAZOL) TABLET [OTSUKA AMERICA PHARMACEUTICAL, INC.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24d75b58-bafb-4440-b8d7-4f4079c08b0b | publisher = | date = | accessdate = }}</ref> | |}<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = PLETAL (CILOSTAZOL) TABLET [OTSUKA AMERICA PHARMACEUTICAL, INC.] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=24d75b58-bafb-4440-b8d7-4f4079c08b0b | publisher = | date = | accessdate = }}</ref> | ||
==References== | ==References== | ||
Revision as of 21:21, 28 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Labels and Packages
PRINCIPAL DISPLAY PANEL - 50mg Bottle Label NDC 59148-003-16
Tablets PLETAL® (cilostazol)
50mg
OTSUKA AMERICA PHARMACEUTICAL, INC.
60 TABLETS
 |
PRINCIPAL DISPLAY PANEL - 100mg Bottle Label NDC 59148-002-16
Tablets PLETAL® (cilostazol)
100mg
OTSUKA AMERICA PHARMACEUTICAL, INC. 60 TABLETS
 |
References
Adapted from the FDA Package Insert.